← Open Payments lookup

VIJAYALAKSHMI LINGAM: Open Payments

NPI 1760496194 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$372 in 6 payments from 5 companies in 2025. Trend: 2023 $21 · 2024 $122 · 2025 $372

Food & beverage: $372
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$124
Janssen Pharmaceuticals, Inc1$110
Luye Pharma (USA) Ltd.1$71
E.R. Squibb & Sons, L.L.C.2$45
Vanda Pharmaceuticals Inc.1$23

Products named: INGREZZA, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, COBENFY, FANAPT.

Industry payments across MI — which companies pay providers there.